Replimune group's chief medical officer sells shares worth $78,111 By...

Published on 20 Nov 2024 on Investing.com

The shares were sold at a price of $10.78 each, amounting to a total transaction value of $78,111....

Read the rest of the article

Start tracking your investments with Statfolio

Tesla, Nvidia among Friday's market cap stock movers

Investing.com 22 Nov 2024

REPL stock soars after submitting a BLA to the FDA seeking accelerated approval for its lead...

Zacks · via Yahoo Finance 22 Nov 2024

Shares of Replimune Group Inc (NASDAQ:REPL) surged more than 19% in after-hours trading following...

Investing.com 22 Nov 2024

The shares were sold at a price of $10.78 each, amounting to a total transaction value of $78,111...

Investing.com 20 Nov 2024

According to a filing with the Securities and Exchange Commission, Sarchi sold 5,207 shares at a...

Investing.com 20 Nov 2024

Overview of the Recent Transaction On September 30, 2024, Morgan Stanley executed a significant t...

GuruFocus.com · via Yahoo Finance 8 Oct 2024

Shares of Replimune Group, Inc. (REPL) have gained 16.4% over the past four weeks to close the la...

Zacks via Yahoo Finance 11 Mar 2024

Replimune Group, Inc. (REPL) could be a solid choice for investors given its recent upgrade to a ...

Zacks via Yahoo Finance 8 Mar 2024

Shares of Replimune Group, Inc. (REPL) have gained 0.8% over the past four weeks to close the las...

Zacks via Yahoo Finance 23 Feb 2024

<img src=https://s.yimg.com/ny/api/res/1.2/GFFacjMQE5JFxUpwjOKI8A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyM...

GuruFocus.com via Yahoo Finance 8 Feb 2024